Abstract
G-protein-coupled receptors (GPCRs) play a major role in psychiatric disorders and are the targets of several current therapeutic approaches in this field. A number of studies have now shown that GPCRs can assemble as high molecular weight homo- and hetero-oligomers, which could affect ligand binding, intracellular signalling or trafficking. This information could be critical in design of new drugs to treat neurological and psychiatric disorders. This chapter describes a sequential co-immunoprecipitation and immunoblot protocol for determining oligomerisation of the 5-hydroxytryptamine (HT)1A receptor with other GPCRs in co-transfected HEK-293 cells.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Schonenbach NS, Hussain S, O'Malley MA (2015) Structure and function of G protein-coupled receptor oligomers: implications for drug discovery. Wiley Interdiscip Rev Nanomed Nanobiotechnol 7:408–427
Komatsu H (2015) Novel therapeutic GPCRs for psychiatric disorders. Int J Mol Sci 16:14109–14121
Franco R, Martínez-Pinilla E, Lanciego JL, Navarro G (2016) Basic pharmacological and structural evidence for class A G-protein-coupled receptor heteromerization. Front Pharmacol 7:76. doi:10.3389/fphar.2016.00076
Salim K, Fenton T, Bacha J, Urien-Rodriguez H, Bonnert T, Skynner HA et al (2002) Oligomerization of G-protein-coupled receptors shown by selective co-immunoprecipitation. J Biol Chem 277:15482–15485
Nelson RM, Long GL (1989) A general method of site-specific mutagenesis using a modification of the Thermus aquaticus polymerase chain reaction. Anal Biochem 180:147–151
Baldi L, Muller N, Picasso S, Jacquet R, Girard P, Thanh HP et al (2005) Transient gene expression in suspension HEK-293 cells: application to large-scale protein production. Biotechnol Prog 21:148–153
Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680–685
Fink K, Zentner J, Gothert M (1995) Subclassification of presynaptic 5-HT autoreceptors in the human cerebral cortex as 5-HT1D receptors. Naunyn Schmiedebergs Arch Pharmacol 352:451–454
Bonaventure P, Voorn P, Luyten WH, Jurzak M, Schotte A, Leysen JE (1998) Detailed mapping of serotonin 5-HT1B and 5-HT1D receptor messenger RNA and ligand binding sites in guinea-pig brain and trigeminal ganglion: clues for function. Neuroscience 82:469–484
Barnes NM, Sharp T (1999) A review of central 5-HT receptors and their function. Neuropharmacology 38:1083–1152
Xie Z, Lee SP, O’Dowd BF, George SR (1999) Serotonin 5-HT1B and 5-HT1D receptors form homodimers when expressed alone and heterodimers when co-expressed. FEBS Lett 456:63–67
Kleinau G, Müller A, Biebermann H (2016) Oligomerization of GPCRs involved in endocrine regulation. J Mol Endocrinol 57:R59–R80
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this chapter
Cite this chapter
Guest, P.C. (2017). Sequential Co-immunoprecipitation and Immunoblot Approach to Determine Oligomerisation of G-Protein-Coupled Receptors. In: Guest, P. (eds) Proteomic Methods in Neuropsychiatric Research. Advances in Experimental Medicine and Biology(), vol 974. Springer, Cham. https://doi.org/10.1007/978-3-319-52479-5_20
Download citation
DOI: https://doi.org/10.1007/978-3-319-52479-5_20
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-52478-8
Online ISBN: 978-3-319-52479-5
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)